Seeking Alpha

AstraZeneca (AZN -0.1%) will appoint a new CEO over the next six months and the person should be...

AstraZeneca (AZN -0.1%) will appoint a new CEO over the next six months and the person should be aggressive on acquisitions, according to Leerink Swann. Leerink views Forest Labs (FRX +3.5%), a stock it upgraded this morning to Outperform, as the most logical takeover target for AZN, but also feels the company has several other options, including Amylin (AMLN -2.7%) and Salix (SLXP -0.1%).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs